The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
EVOLVE-1: Phase 3 study of everolimus for advanced HCC that progressed during or after sorafenib.
Andrew X. Zhu
Consultant or Advisory Role - Daiichi Sankyo; Eisai; Sanofi
Research Funding - Bayer; ImClone Systems; Lilly; Novartis; Onyx
Masatoshi Kudo
Consultant or Advisory Role - Novartis
Eric Assenat
Consultant or Advisory Role - Novartis
Stéphane Cattan
No relevant relationships to disclose
Yoon-Koo Kang
Consultant or Advisory Role - Bayer; Novartis; Roche; Sanofi
Research Funding - Bayer; Novartis; Roche; Sanofi
Ho Yeong Lim
No relevant relationships to disclose
Ronnie Tung Ping Poon
Consultant or Advisory Role - Novartis
Jean-Frédéric Blanc
No relevant relationships to disclose
Arndt Vogel
No relevant relationships to disclose
Chao-Long Chen
No relevant relationships to disclose
Etienne Dorval
No relevant relationships to disclose
Markus Peck-Radosavljevic
Consultant or Advisory Role - ArQule (U); Bayer Schering Pharma (U); Boehringer Ingelheim (U); Daiichi Sankyo (U)
Honoraria - Abbott Laboratories; Bayer Schering Pharma; Lilly; Novartis
Research Funding - Bayer Schering Pharma
Armando Santoro
No relevant relationships to disclose
Bruno Daniele
Consultant or Advisory Role - Bayer; Daiichi Sankyo
Honoraria - Bayer; Daiichi Sankyo; Novartis
Junji Furuse
Honoraria - Novartis
Annette Jappe
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Kevin Perraud
Employment or Leadership Position - Novartis
Ozlem Anak
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Dalila B. Sellami
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Li-Tzong Chen
Honoraria - Novartis
Research Funding - Novartis